| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| Q0513 |
Pharmacy dispensing fee for inhalation drug(s); per 30 days |
733 |
716 |
$648.45 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
460 |
452 |
$504.12 |
| J7605 |
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
251 |
246 |
$218.08 |
| G0333 |
Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary |
15 |
15 |
$0.00 |
| J7677 |
Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram |
66 |
66 |
$0.00 |